Sign in

    Brian P. Angeli

    EVP and Chief Marketing Officer at FMC Corp
    Since May 1, 2024
    Age
    48 years
    Education
    Holds a Bachelor of Science in Accounting and Finance from Boston College and an MBA from New York University Stern School of Business.
    Tenure
    Joined FMC in 2014 and held various leadership roles including Vice President of Corporate Strategy and Development, Treasurer, Transformation Officer, and Vice President of Investor Relations and Corporate Development before being promoted to Executive Vice President and Chief Marketing Officer in May 2024.

    Also at FMC Corp

    ADS
    Andrew D. Sandifer
    Executive Vice President and CFO
    JS
    Jacqueline Scanlan
    EVP and Chief Human Resources Officer
    MFR
    Michael F. Reilly
    EVP, General Counsel, Chief Compliance Officer, and Secretary

    About

    Brian P. Angeli is a seasoned executive with extensive experience in strategic leadership and financial management. He joined FMC in 2014 and has since contributed to numerous significant initiatives and acquisitions, including the 2014 acquisition of Cheminova, the 2017 asset swap with DuPont, and the 2022 acquisition of BioPhero, as well as leading the separation of FMC's Lithium business through an IPO and subsequent spin-off.

    Before his tenure at FMC, he developed his expertise in investment banking and financial diligence through roles at The Goldman Sachs Group and PricewaterhouseCoopers. These roles equipped him with a strong foundation in mergers and acquisitions in the industrial and natural resources sectors.

    He is a Certified Public Accountant who holds a Bachelor of Science in Accounting and Finance from Boston College and an MBA from New York University Stern School of Business, underpinning his strong academic background with practical experience. His well-rounded career and commitment to strategic excellence underscore his contributions to FMC’s global operations and growth.

    Past Roles

    OrganizationRoleDate RangeDetails
    FMC CorporationVice President, Investor Relations and Corporate DevelopmentPre-May 2024 Involved in major deals including the 2014 acquisition of Cheminova, 2017 DuPont asset swap, 2022 acquisition of BioPhero, Lithium IPO in 2018 and spin-off in 2019
    FMC CorporationTransformation OfficerPre-May 2024 Played a key role in strategic initiatives
    FMC CorporationTreasurerPre-May 2024 N/A
    FMC CorporationVice President, Corporate Strategy and DevelopmentPre-May 2024 N/A
    The Goldman Sachs Group, Inc.Vice President, Investment BankingPrior to FMC Focused on mergers and acquisitions in the industrial and natural resources sectors
    PricewaterhouseCoopers, LLPDirector, Financial and Accounting DiligencePrior to FMC Directed financial and accounting diligence for Fortune 500 clients